Results 11 to 20 of about 986,336 (320)

Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation.

open access: yesLancet, The, 1994
J. Vandenbroucke   +5 more
semanticscholar   +3 more sources

A Rare Case of Quadruple Limb Amputation due to Factor V Leiden Mutation

open access: yesIndian Journal of Physical Medicine & Rehabilitation, 2022
Factor V Leiden, an autosomal dominant gene mutation that leads to increase risk of forming thrombophilia. Amputation in patients with Factor V leiden mutation is known but none describe quad-limb amputation in this setting.
Ann Noble Zachariah, Ravi Sankaran
doaj   +1 more source

The risk of recurrent deep venous thrombosis among heterozygous carriers of both factor V Leiden and the G20210A prothrombin mutation.

open access: yesNew England Journal of Medicine, 1999
V. De Stefano   +7 more
semanticscholar   +3 more sources

Factor V Leiden [PDF]

open access: yesCirculation, 2003
You may have been tested for the condition known as factor V Leiden (pronounced factor five lye/-den) because you or someone in your family has had a blood clot in one of the deep veins of the body (also called deep vein thrombosis, or DVT) or a blood clot that traveled to the lung (also called a pulmonary embolism, or PE).
Deborah L. Ornstein, Mary Cushman
openaire   +3 more sources

Comparative analysis of “APTT vs RVVT” based activated protein C resistance assay in the diagnosis of Factor V Leiden mutation

open access: yesIndian Journal of Pathology and Microbiology, 2020
Background: Thrombophilia is a hypercoagulable state characterized by increased venous thrombosis. The most common cause of heritable thrombophilia is Factor V Leiden (FVR506Q) homozygous state, with a relative risk of 10–80 times as compared to normal ...
Mirza Asif Baig
doaj   +1 more source

Factor V Leiden and Inflammation [PDF]

open access: yesThrombosis, 2012
Factor V Leiden, is a variant of human factor V (FV), also known as proaccelerin, which leads to a hypercoagulable state. Along these years, factor V Leiden (FVL) has been studied from the pathophysiologic point of view, and research has been focused on finding clinical approaches for the management of the FVL associated to a trombophilic state.
Silvia Perez-Pujol   +2 more
openaire   +2 more sources

Frequency of factor II G20210A, factor V Leiden, MTHFR C677T and PAI-1 5G/4G polymorphism in patients with venous thromboembolism: Croatian case-control study [PDF]

open access: yes, 2010
Introduction: Venous thromboembolic disease is one of the leading causes of morbidity and mortality in the developed world. Identification of hereditary factors of thrombophilia is contributing to a better understanding of the etiology and disease ...
Ana-Maria Simundic   +7 more
core   +2 more sources

Hormonal replacement therapy, prothrombotic mutations and the risk of venous thrombosis [PDF]

open access: yes, 2002
Hormone replacement therapy (HRT) increases the risk of venous thrombosis. We investigated whether this risk is affected by carriership of hereditary prothrombotic abnormalities.
A. Rumley   +26 more
core   +1 more source

Recurrent pregnancy loss: can factor V Leiden mutations be a cause [PDF]

open access: yesObstetrics & Gynecology Science, 2019
The role of Factor V Leiden (FVL) mutation in recurrent miscarriages has been disputed. It has been hypothesized that FVL mutation in patients with recurrent miscarriages is treatable.
R R N Reddy   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy